These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10197410)

  • 61. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
    Ohata I; Sakamoto N; Nitatori R; Maeno H
    Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
    Parker RA; Kariya T; Grisar JM; Petrow V
    J Med Chem; 1977 Jun; 20(6):781-91. PubMed ID: 406395
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV; Metz G
    Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical trials with gugulipid. A new hypolipidaemic agent.
    Nityanand S; Srivastava JS; Asthana OP
    J Assoc Physicians India; 1989 May; 37(5):323-8. PubMed ID: 2693440
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
    Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
    Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
    Goldberg AP; Applebaum-Bowden DM; Bierman EL; Hazzard WR; Haas LB; Sherrard DJ; Brunzell JD; Huttunen JK; Ehnholm C; Nikkila EA
    N Engl J Med; 1979 Nov; 301(20):1073-6. PubMed ID: 226883
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.
    Wolfe BM; Kane JP; Havel RJ; Brewster HP
    J Clin Invest; 1973 Sep; 52(9):2146-59. PubMed ID: 4353773
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of clofibrate on fatty acid desaturation of rats treated with ethanol.
    Peluffo RO; Nervi AM; Brenner RR
    Acta Physiol Lat Am; 1981; 31(2):119-28. PubMed ID: 6821269
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ethyl 2-([5,6-dihydro-7-(1H-imidazol-1-yl)-2-naphthalenyl]oxy)- 2-methylpropanoate as a new potent oxyisobutyrate hypolipidaemic with unusual features.
    Cozzi P; Branzoli U; Carganico G; Chiari A; Lovisolo PP; Severino D
    Farmaco Sci; 1987 Mar; 42(3):205-18. PubMed ID: 3653387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. alpha-asarone congeners as hypolipidemic agents. Pseudoreceptor versus minireceptor modeling.
    Filipek S; Łozowicka B
    Acta Pol Pharm; 2000 Nov; 57 Suppl():106-9. PubMed ID: 11293234
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hypolipidaemic and antioxidant properties of ethanol extract from Flos populi.
    Zhao Y; Tang G; Cai E; Liu S; Zhang L; Wang S
    Nat Prod Res; 2014; 28(18):1467-70. PubMed ID: 24730759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drugs affecting triglycerides.
    Capurso A
    Cardiology; 1991; 78(3):218-25. PubMed ID: 1868499
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypolipemic activity of plafibride.
    Bruseghini L; Vilageliu J; Bagaria A
    Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of soybean phospholipid, chlorella phospholipid, and clofibrate on collagen and elastin synthesis in the aorta and on the serum and liver lipid contents in rats.
    Hashimoto S; Setoyama T; Yokokura T; Mutai M
    Exp Mol Pathol; 1982 Feb; 36(1):99-106. PubMed ID: 7198996
    [No Abstract]   [Full Text] [Related]  

  • 75. Hypolipidemic activity of 6-amino-2-mercapto-5-methyl-pyrimidine-4-carboxylic acid and related derivatives in rodents.
    Hall IH; Cocolas GH; Murthy AR; Rhyne KA; Knowles M
    J Pharm Sci; 1985 Jul; 74(7):759-64. PubMed ID: 4032250
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
    Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
    Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of drugs on postprandial lipoprotein metabolism.
    Packard CJ
    Proc Nutr Soc; 1997 Jul; 56(2):745-51. PubMed ID: 9264125
    [No Abstract]   [Full Text] [Related]  

  • 78. Biological evaluation of a siliconized analog of clofibrate (silafibrate) in rodents.
    Ziaee M; Eghbal MA; Rahmani J; Ghaffarzadeh M; Khorrami A; Garjani A
    Iran J Pharm Res; 2013; 12(3):471-81. PubMed ID: 24250653
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hypolipidaemic aryloxyacetic acids.
    Schacht E
    Top Curr Chem; 1977; 72():99-123. PubMed ID: 339406
    [No Abstract]   [Full Text] [Related]  

  • 80. Hypolipidemic activity of phthalimide derivatives IV: Further chemical modification and investigation of the hypolipidemic activity of N-substituted imides.
    Chapman JM; Cocolas GH; Hall IH
    J Pharm Sci; 1983 Nov; 72(11):1344-7. PubMed ID: 6644601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.